Salt Lake City, UT – According to filings with the U.S. Securities and Exchange Commission, J3 Bioscience is raising $1,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Tyler Mccabe played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About J3 Bioscience
J3 Bioscience (J3 Bio) is a commercialization-stage women’s health and wellness company. Our lead product, known as the LivRing, is an FDA cleared and patented intravaginal ring (IVR) that is intended as a long-lasting vaginal lubricating moisturizer, and provides a method to enhance the ease and comfort of sexual activity and supplement the bodys natural lubrication. The LivRing offers women many unique and distinct advantages over alternative devices, including seven-day, controlled-release of a lubricating moisturizer longer than anything currently on the OTC market. Its easy-to-use, long-lasting, safe, not made with hormones, not made with fragrance, and an innovative product that provides continuous moisture and lubrication.

To learn more about J3 Bioscience, visit http://j3bio.com/

Contact:
Tyler Mccabe, Chief Executive Officer
801-931-4756

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved